Dr. Kremen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
127 S. San Vicente Blvd
#A6600
Los Angeles, CA 90048Phone+1 310-423-6472Fax+1 310-423-0148- Is this information wrong?
Summary
- I am a board-certified behavioral neurologist with an interest in clinical care, clinical research, and public outreach and education. I see patients with neurodegenerative conditions, epilepsy, stroke, and other conditions that cause changes in language, memory, visual spatial, and frontal executive functioning. I am an experienced site PI for industry and academic clinical trials and observational studies of Alzheimer's disease. I also led the UCLA California Alzheimer's Disease Center for over 5 years. I am a member of the Medical Scientific Board of Alzheimer's Los Angeles.
Education & Training
- VA Greater Los Angeles Healthcare SystemFellowship, Special Fellowship In Geriatric Neurology, 2009 - 2010
- Greater Los Angeles HCSNeuropsychiatry and Behavioral Neurology, 2007 - 2009
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2004 - 2007
- UCLA-VA Greater Los AngelesInternship, Internal Medicine, 2003 - 2004
- University of Maryland School of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2004 - 2024
- American Board of Psychiatry and Neurology Neurology
- UCNSBehavioral Neurology and Neuropsychiatry
Clinical Trials
- Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease Start of enrollment: 2012 Oct 05
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) Start of enrollment: 2013 Nov 05
- Join now to see all
Publications & Presentations
PubMed
- Dementia Prevention and Treatment: A Narrative Review.David B Reuben, Sarah Kremen, Donovan T Maust> ;JAMA Internal Medicine. 2024 Mar 4
- 14 citationsRecommendations to address key recruitment challenges of Alzheimer's disease clinical trials.Jessica B Langbaum, Julie Zissimopoulos, Rhoda Au, Niranjan Bose, Chris J Edgar, Evan Ehrenberg, Howard Fillit, Carl V Hill, Lynne Hughes, Michael Irizarry, Sarah Krem...> ;Alzheimer's & Dementia. 2023 Feb 1
- 26 citationsPatient and caregiver reactions to clinical amyloid imagingJoshua D. Grill, Chelsea G. Cox, Sarah Kremen, Mario F. Mendez, Edmond Teng, Jill S. Shapira, John M. Ringman, Liana G. Apostolova> ;Alzheimer's & Dementia. 2017 Aug 1
- Join now to see all
Press Mentions
- Checking Your Health: Surprising Risk Factors That Play Role in Cognitive DeclineFebruary 9th, 2023
- First Drug Proven to Slow Alzheimer’s Won’t Be Available to Most Patients for Several MonthsFebruary 6th, 2023
- Why a New Alzheimer's Drug Is Having a Slow US DebutFebruary 5th, 2023
- Join now to see all
Grant Support
- Alzheimer’s Disease Center of California at UCLACalifornia Department of Public Health/Alzheimer’s Disease Program2015–2021
Professional Memberships
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: